Khiron Life Revenue vs. EBITDA

KHRNF Stock  USD 0.0001  0.00  0.00%   
Based on the measurements of profitability obtained from Khiron Life's financial statements, Khiron Life Sciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Khiron Life's ability to earn profits and add value for shareholders.
For Khiron Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Khiron Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Khiron Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Khiron Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Khiron Life Sciences over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Khiron Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Khiron Life Sciences EBITDA vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth.
Khiron Life Sciences is considered the number one company in revenue category among its peers. It is rated fourth overall in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Khiron Life's earnings, one of the primary drivers of an investment's value.

Khiron Revenue vs. Competition

Khiron Life Sciences is considered the number one company in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is now estimated at about 13.82 Million. Khiron Life totals roughly 12.79 Million in revenue claiming about 93% of equities under Drug Manufacturers—Specialty & Generic industry.

Khiron EBITDA vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Khiron Life

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
12.79 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Khiron Life

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(32.03 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Khiron EBITDA Comparison

Khiron Life is currently under evaluation in ebitda category among its peers.

Khiron Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Khiron Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Khiron Life will eventually generate negative long term returns. The profitability progress is the general direction of Khiron Life's change in net profit over the period of time. It can combine multiple indicators of Khiron Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.

Khiron Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Khiron Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Khiron Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Khiron Life's important profitability drivers and their relationship over time.

Use Khiron Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Khiron Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Khiron Life will appreciate offsetting losses from the drop in the long position's value.

Khiron Life Pair Trading

Khiron Life Sciences Pair Trading Analysis

The ability to find closely correlated positions to Khiron Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Khiron Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Khiron Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Khiron Life Sciences to buy it.
The correlation of Khiron Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Khiron Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Khiron Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Khiron Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Khiron Life position

In addition to having Khiron Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Climate Change Thematic Idea Now

Climate Change
Climate Change Theme
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Khiron Pink Sheet

To fully project Khiron Life's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Khiron Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Khiron Life's income statement, its balance sheet, and the statement of cash flows.
Potential Khiron Life investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Khiron Life investors may work on each financial statement separately, they are all related. The changes in Khiron Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Khiron Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.